Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Obagi Nu-Derm
- Development stage
- Unknown
- Lead developer
- Obagi
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Obagi Nu-Derm** is a prescription topical skincare system for hyperpigmentation and visible photodamage. Its core prescription products, including Clear, Blender, and Sunfader, contain **hydroquinone USP 4%**; certain system components also contain sunscreen actives. Hydroquinone produces reversible depigmentation by inhibiting tyrosinase-mediated oxidation of tyrosine to DOPA, suppressing melanogenesis. The system is marketed for gradual bleaching of melasma, chloasma, freckles, senile lentigines, and other areas of melanin hyperpigmentation. Obagi Nu-Derm originated at Obagi Medical and has subsequently been owned or developed through Valeant Pharmaceuticals, Hologic, Waldencast, and Bridgepoint.
- Brand names
- Nu-DermObagi Nu-Derm
- Other names
- Obagi Nu-Derm System Normal-Oily Skin Transformation TrialOBAGI NU-DERM FX SYSTEM
02
Targets
TYR (Tyrosinase)
Beyond the preview
Go deeper on Obagi Nu-Derm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Obagi Nu-Derm.